Veterinary Medicine Information website

Febrivac HV Vet. lyofilisat og solvens til injektionsvæske, suspension

Authorised
  • Canine distemper virus, strain Lederle D84/1, Live

Product identification

Medicine name:
Febrivac HV Vet. lyofilisat og solvens til injektionsvæske, suspension
Active substance:
  • Canine distemper virus, strain Lederle D84/1, Live
Target species:
  • Fur animals
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle D84/1, Live
    5012.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CD01
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 39060
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, LYOFILISAT OG SOLVENS TIL INJEKTIONSVÆSKE, SUSPENSION)
Published on: 29/06/2023